Study in Heart Rhythm Shows AI Algorithms Cut Alert Burden with PaceMate’s Data Capabilities

A recent study published in Heart Rhythm highlights how artificial intelligence (AI) algorithms embedded in Medtronic’s LINQ II implantable loop recorders (ILRs) significantly reduce alert and episode burdens. This is achieved through data analysis powered by PaceMate’s flagship product, PaceMateLIVE™.

The study, titled Use of Artificial Intelligence Algorithms to Reduce Transmissions in Implantable Loop Recorders, marks an important advancement in reducing the workload associated with remote cardiac monitoring. Researchers from multiple institutions found that AI-driven algorithms led to a 20% reduction in alert burdens and a 40% reduction in episode burdens for patients monitored with LINQ II devices. These FDA-approved algorithms, released in early 2022, filter out false-positive alerts for atrial fibrillation and pauses before data reaches clinical teams.

The research used a large de-identified dataset from 26 U.S. healthcare centers, with transmissions centrally received and analyzed by CareLink, then filtered by PaceMate’s expert staff. The PaceMateLIVE platform enabled researchers to assess the full impact of the AccuRhythm AI’s filtering capabilities on clinical alert volume and efficiency.

Key Findings:

  • 20% Reduction in Alert Burden: AI filtering significantly reduces the number of non-critical alerts requiring clinician attention.
  • 40% Reduction in Episode Burden: AI algorithms help eliminate redundant episodes, streamlining the data that reaches healthcare teams for review.

Tripp Higgins, CEO of PaceMate®, commented on the study’s findings: “This research demonstrates the transformative power of innovative technology in cardiac remote monitoring. By reducing unnecessary alerts and simplifying data workflows, PaceMateLIVE enables clinicians to focus on what truly matters—delivering timely and targeted care to patients. We’re proud to play a key role in advancing these solutions.”

The data from PaceMateLIVE’s advanced monitoring and analysis platform showcases AI’s potential to transform cardiac remote monitoring by reducing clinician workload and enhancing patient care.

About PaceMate
PaceMate is a leader in remote cardiac data management, dedicated to modernizing digital healthcare and shaping the future of connected, personalized cardiac care. Since 2015, PaceMate has simplified and streamlined device clinic operations through its platform, PaceMateLIVE. As the only comprehensive cardiac remote monitoring solution, PaceMateLIVE pairs device and EHR data, intelligently prioritizing patient care. Visit us at PaceMate.com to learn how we never miss a beat.®

Source link

Newsletter Updates

Enter your email address below and subscribe to our newsletter